Neurotoxicity from oxaliplatin

Thompson, Lisa A.
May 2013
Oncology Nurse Advisor;May/Jun2013, Vol. 4 Issue 3, p60
The article presents a question and answer related to the potential autonomic issues associated with acute neurotoxicity from oxaliplatin.


Related Articles

  • A curious case of oxaliplatin-induced neurotoxicity: Recurrent, self-limiting dysarthria. Joseph, Ranjit; Dasanu, Constantin A // Journal of Oncology Pharmacy Practice;Oct2014, Vol. 20 Issue 5, p393 

    This report presents a unique case of oxaliplatin-induced neurotoxicity featuring acute, recurrent, self-limiting dysarthria following multiple subsequent infusions of oxaliplatin. A 65-year-old man started chemotherapy for metastatic pancreatic adenocarcinoma with...

  • Clinical Study of Jiawei Huangqi Guizhi Wuwu Decoction in Preventing and Treating Peripheral Neuro-sensory Toxicity Caused by Oxaliplatin. Li Yuan; Cui Hui-Juan; Huang Jin-Chang; Wit Xiao-qin // Chinese Journal of Integrative Medicine;Mar2006, Vol. 12 Issue 1, p19 

    Objective: To evaluate the efficacy of Jiawei Huangqi Guizhi Wuwu Decoction (JHGWD) in treating neuro-sensory toxicity induced by oxaliplatin. Methods: A randomized controlled self-crossover trial was performed. Thirty-one patients were randomly divided into AB and BA groups. Patients in A cycle...

  • Oxaliplatin acute neurotoxicity and the role of Ca/Mg infusions. Oholendt, Andrea Landgraf // Hem/Onc Today;9/25/2009, Vol. 10 Issue 18, p17 

    The article discusses oxaliplatin-induced acute neurotoxicity.

  • Valproik Aside BaÄŸl› Üç Ensefalopati Olgusu. Polat, Fatma; Köşkderelioğlu, Aslı; Alpaydın, Sezin; Keskinöz, Nesli; Araç, Nilgün; Gönül, Ali Saffet; Kocaman, Ayşe; İirin, Hadiye // Turkish Journal of Neurology / Turk Noroloji Dergisi;Sep2010, Vol. 16 Issue 3, p203 

    Valproic acid-induced encephalopathy is a serious complication of valproate, rarely observed, and can lead to death if early diagnosis is not made. It is clinically presented as mental status changes that range from drowsiness to lethargy and coma, focal or bilateral neurological deficits,...

  • Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer. Lucchetta, Marta; Lonardi, Sara; Bergamo, Francesca; Alberti, Paola; Velasco, Roser; Argyriou, Andreas; Briani, Chiara; Bruna, Jordi; Cazzaniga, Marina; Cortinovis, Diego; Cavaletti, Guido; Kalofonos, Haralabos // Cancer Chemotherapy & Pharmacology;Dec2012, Vol. 70 Issue 6, p899 

    Context: Peripheral, acute or chronic, neurotoxicity is one of the main dose-limiting adverse effects of oxaliplatin (OXA). Acute neurotoxicity is typically characterized by distal and perioral cold-induced paresthesias and dysesthesias, but other uncommon symptoms might also be present....

  • CASE REPORT: Blepharoptosis following oxaliplatin administration. Lau, S. Cecilia; Shibata, Stephen I. // Journal of Oncology Pharmacy Practice;Dec2009, Vol. 15 Issue 4, p255 

    Oxaliplatin is a unique platinum derivative with anti-tumor activity in a number of malignancies, with neurotoxicity being a frequent side effect. Neurotoxicity can manifest in an acute phase and a chronic phase. The acute phase usually presents as dysesthesias of the hands and feet, jaw...

  • Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy. Park, Susanna B.; Lin, Cindy S.-Y.; Krishnan, Arun V.; Goldstein, David; Friedlander, Michael L.; Kiernan, Matthew C. // Brain: A Journal of Neurology;Oct2009, Vol. 132 Issue 10, p2712 

    Administration of oxaliplatin, a platinum-based chemotherapy used extensively in the treatment of colorectal cancer, is complicated by prominent dose-limiting neurotoxicity. Acute neurotoxicity develops following oxaliplatin infusion and resolves within days, while chronic neuropathy develops...

  • The Pathophysiology of Oxaliplatin-Induced Neurotoxicity. Kiernan, Matthew C.; Krishnan, Arun V. // Current Medicinal Chemistry;2006, Vol. 13 Issue 24, p2901 

    Nerve dysfunction is a common accompaniment of chemotherapy, typically occurring in a dose-dependent manner, so that the higher the dose and the longer the time of exposure, the more likely neuropathy is to occur. With the majority of chemotherapies, the mechanisms of neurotoxicity have not been...

  • Gemcitabine/oxaliplatin/paclitaxel.  // Reactions Weekly;May2014, Vol. 1503 Issue 1, p21 

    An abstract of the article "Sustained response with gemcitabine plus Nab-paclitaxel after folfirinox failure in metastatic pancreatic cancer: Report of an effective new strategy," by A. Portal and colleagues is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics